Johnson & Johnson (NYSE:JNJ) announced it is recalling a couple of lots of its Topamax antiseizure drug after receiving complaints of an odd odor coming from the products.
The source of the odor is apparently chemically treated wooden pallets. The company is looking into whether or not other products may be affected in a similar manner.
What caused the problem was pallets that were mislabeled, resulting in the product being placed upon them for shipping.
"The entire supply chain organization is looking at this," J&J spokeswoman Carol Goodrich said.
Johnson and Johnson was trading at $59.90, up $0.30, or 0.50 percent.
Thursday, April 14, 2011
Johnson & Johnson (JNJ) Recalls Two Topamaz Lots
Labels:
Johnson and Johnson,
Recall
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment